Wolverine Asset Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-8,700
Closed -$139K 1641
2018
Q1
$139K Hold
8,700
﹤0.01% 1191
2017
Q4
$164K Sell
8,700
-12,000
-58% -$217K ﹤0.01% 1100
2017
Q3
$291K Buy
+20,700
New +$187K ﹤0.01% 932
2017
Q2
Sell
-21,100
Closed -$137K 1483
2017
Q1
$137K Sell
21,100
-12,400
-37% -$69.3K ﹤0.01% 903
2016
Q4
$148K Buy
33,500
+16,000
+91% +$67.1K ﹤0.01% 867
2016
Q3
$81K Sell
17,500
-101,700
-85% -$603K ﹤0.01% 1000
2016
Q2
$783K Buy
119,200
+117,760
+8,178% +$832K 0.01% 617
2016
Q1
$36K Buy
1,440
+1,289
+854% +$6.61K ﹤0.01% 922
2015
Q4
$1K Buy
+151
New +$864 ﹤0.01% 1646
2015
Q2
Sell
-1,725
Closed -$29K 2057
2015
Q1
$29K Buy
1,725
+711
+70% +$4.73K ﹤0.01% 1372
2014
Q4
$7K Hold
1,014
﹤0.01% 1822
2014
Q3
$21K Buy
1,014
+1,002
+8,350% +$7.84K ﹤0.01% 1800
2014
Q2
$4K Sell
12
-1,596
-99% -$12.1K ﹤0.01% 2072
2014
Q1
$48K Buy
1,608
+48
+3% +$406 ﹤0.01% 1359
2013
Q4
$66K Buy
1,560
+1,550
+15,500% +$13.8K ﹤0.01% 1667
2013
Q3
$4K Hold
10
﹤0.01% 2444
2013
Q2
$5K Buy
+10
New +$77 ﹤0.01% 2363

Other funds holding SPPI

Wolverine Asset Management's SPPI Position: Q1 2020 in Review

Wolverine Asset Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q1 2020, closing a stake of 109 shares.

Wolverine Asset Management first reported a position in SPPI in Q2 2013 and held it in 7 quarters. The position peaked at $99K in Q3 2013. 156 funds tracked by Wall St. Rank hold SPPI as of Q1 2020.

  • Wolverine Asset Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q1 2020 after selling out during the quarter.
  • Wolverine Asset Management sold 109 Spectrum Pharmaceuticals Inc shares in Q1 2020.
  • Wolverine Asset Management first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 7 quarters.
  • Wolverine Asset Management's Spectrum Pharmaceuticals Inc position peaked at $99K in Q3 2013.
  • 156 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q1 2020.

Based on Wolverine Asset Management's 13F filing for Q1 2020, filed 13 May 2020.